Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy.
Esaki M, Takemura G, Kosai K, Takahashi T, Miyata S, Li L, Goto K, Maruyama R, Okada H, Kanamori H, Ogino A, Ushikoshi H, Minatoguchi S, Fujiwara T, Fujiwara H.
Esaki M, et al. Among authors: minatoguchi s.
Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H1048-57. doi: 10.1152/ajpheart.01102.2007. Epub 2007 Dec 14.
Am J Physiol Heart Circ Physiol. 2008.
PMID: 18083897
Free article.